Novartis Ag (NVS) Invested Capital (2009 - 2026)
Novartis Ag's Invested Capital was $79.44 billion in Q2 2026, up 23.1% from $64.52 billion a year earlier and up 4.0% from the prior quarter.
Analysis
Novartis Ag (NVS) Invested Capital (2009 - 2026) Analysis & Trends
For FY2025, Invested Capital at Novartis Ag came in at $75.17 billion, up 13.7% from FY2024.
- Invested Capital shows a five-year compound annual growth rate of -2.2% (FY2020 to FY2025).
- In earlier years, Invested Capital was $66.13 billion in FY2024 (+0.5%), $65.81 billion in FY2023 (-18.3%), $80.53 billion in FY2022 (+7.4%) and $75.02 billion in FY2021 (-10.6%).
- The Q2 2026 figure marks the highest quarterly Invested Capital since Q4 2022.
- Compared with a year earlier, Invested Capital has increased for eight straight quarters, with growth averaging 11.8% over the last eight quarters.
- The best year-over-year quarter for Invested Capital over five years was Q1 2026 (growth of 27.0%); the worst was Q3 2023 (a decline of 30.2%).
- Per Business Quant data, NVS's Invested Capital in the three quarters before Q2 2026 was $76.37 billion (Q1 2026), $75.17 billion (Q4 2025) and $67.35 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.58 Bn | 1,078.16 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 630.16 Bn | 548.69 Bn | 17.26 Bn | 134.01 Bn |
| 3 | AbbVie | 488.57 Bn | 461.73 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 359.15 Bn | 313.58 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 274.32 Bn | 238.71 Bn | 11.24 Bn | 51.53 Bn |
| 6 | Astrazeneca | 246.73 Bn | 220.50 Bn | 12.86 Bn | 44.56 Bn |
| 7 | Amgen | 224.28 Bn | 179.68 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 187.60 Bn | 161.71 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 161.13 Bn | 108.08 Bn | 10.94 Bn | 148.69 Bn |
| 10 | Vertex Pharmaceuticals | 129.23 Bn | 101.23 Bn | 2.84 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 51.53 Bn |
| Mar 31, 2026 | 46.54 Bn |
| Dec 31, 2025 | 52.83 Bn |
| Sep 30, 2025 | 52.27 Bn |
| Jun 30, 2025 | 50.37 Bn |
| Mar 31, 2025 | 46.25 Bn |
| Dec 31, 2024 | 53.00 Bn |
| Sep 30, 2024 | 50.01 Bn |
| Jun 30, 2024 | 49.43 Bn |
| Mar 31, 2024 | 48.10 Bn |
| Dec 31, 2023 | 53.55 Bn |
| Sep 30, 2023 | 43.70 Bn |
| Jun 30, 2023 | 60.22 Bn |
| Mar 31, 2023 | 59.11 Bn |
| Dec 31, 2022 | 66.22 Bn |
| Sep 30, 2022 | 67.95 Bn |
| Jun 30, 2022 | 70.05 Bn |
| Mar 31, 2022 | 68.40 Bn |
| Dec 31, 2021 | 75.02 Bn |
| Sep 30, 2021 | 66.27 Bn |
API Access
Novartis Ag Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=NVS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();